Congresswoman Maloney understands that the health of her constituents and all American citizens has to be prioritized for the country to grow and thrive.
Affordable Care Act and Health Care: All American citizens deserve to have access to good and affordable health care. Thanks to the Patient Protection and Affordable Care Act, millions more Americans are able to secure affordable, quality and accessible health care. Signed into law in 2010, Americans of all ages are already seeing expanded health insurance coverage and cost savings. Congresswoman Maloney is a proud supporter of this historic law that makes for a healthier America and strengthens the country’s economic security. Read more.
Funding for the National Institutes of Health: The National Institutes of Health is responsible for cutting edge research to develop novel, innovative, and ground-breaking medicine and technology that can cure diseases like Parkinson’s, spinal cord injuries and organ failure. Congresswoman Maloney is a strong supporter of federal funding for NIH research to allow researchers at NIH to continue their life-saving work.
Parkinson’s Disease: Parkinson’s disease is one of the many diseases Congresswoman Maloney hopes will reap the benefits of federally funded medical research. The Congresswoman has worked hard to combat Parkinson’s disease by fighting for federal funding to support research on the disease, as well as by increasing public awareness about the challenges faced by millions of Americans suffering from Parkinson’s. Read More.
Skin Cancer Prevention: In 2007, Congresswoman Maloney introduced the Tanning Accountability and Notification (TAN) Act, which required the Food and Drug Administration to determine whether the current labeling of indoor tanning beds provides sufficient information about the risks associated with indoor tanning. Read more.
Vaccines: Congresswoman Maloney believes that vaccines are safe, effective, and absolutely essential for public health by preventing the suffering and costs of infectious diseases, and has been continually supportive of programs and legislation that would ensure people have access to vaccines both at home and abroad. She has and continues to work with her colleagues to combat misinformation about vaccines and encourages all families to follow the guidance of their doctors. Read more.
For other legislation and related documents click here.
More on Health
NEW YORK, NY – Today, Congresswoman Carolyn B.
Washington, D.C. (August 19, 2021)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform; Rep. Diana DeGette, Co-Chair of the Pro-Choice Caucus; Rep. Barbara Lee, Co-Chair of the Pro-Choice Caucus; and Rep. Ayanna Pressley, Committee on Oversight and Reform Member and Chair of the Pro-Choice Caucus’s Abortion Rights and Access Task Force, announced a resolution in support of equitable, science-based policies governing access to medication abortion care.
WASHINGTON, DC – Congresswoman Carolyn B. Maloney (D-NY) and Congressman Donald M. Payne, Jr. (D-NJ) today introduced a resolution to designate August as National Health Care Awareness Month. This designation would bring attention to all the ways in which health care affects all Americans – as a nation and as individuals.
Currently, approximately 32.8 million people under the age of 65 and approximately 4.4 million children are uninsured– with individuals of color at a higher risk of lacking insurance.
A powerful group of Democrats introduced new legislation Wednesday in both the Senate and the House targeting non-debtor releases in bankruptcy cases, pointing specifically to releases like the one in Purdue Pharma's Chapter 11 plan allowing the Sackler family to dodge liability for its role in the opioid crisis.
The Justice Department said Monday it has "fundamental concerns" with Purdue Pharma’s plan to exit Chapter 11 bankruptcy protection.
Six Democratic congresswomen are urging President Joe Biden and congressional leaders to address racial disparities in maternal health as part of upcoming legislation, such as the proposed reconciliation package, slated to include many of Biden’s social and climate agenda items.
House Oversight Committee Chairwoman Carolyn Maloney and five of her colleagues drafted letters to Biden, as well as House Speaker Nancy Pelosi and Senate Majority Leader Chuck Schumer, arguing that the COVID-19 outbreak has exacerbated the maternal health crisis.
In a groundbreaking report released on Wednesday, a federal watchdog estimated that the cost of medical treatment for survivors of gun injuries in the United States amounts to at least $1 billion each year, but is likely much higher.
The new assessment from the Government Accountability Office, Congress’s nonpartisan investigative arm, used recent hospital data to determine that injuries sustained from firearms led to about 50,000 emergency department visits and 30,000 instances of inpatient treatment annually.
Treating firearm-related injuries in the U.S. costs more than $1 billion annually, with public health programs like Medicaid picking up most of the tab, according to new Government Accountability Office estimates shared with POLITICO.
The assessment was requested by House and Senate Democrats last year and comes as the Biden administration is encouraging cities to spend unused Covid relief funds to address gun violence.
The cost of initial treatment for gun-related injuries in hospitals exceeds $1 billion per year, with public health coverage accounting for the majority of the bill, according to a Government Accountability Office (GAO) report.
The GAO’s report released Wednesday found hospitals documented about 30,000 in-patient stays and about 50,000 emergency department visits for initial treatment for gun-related injuries per year, according to most recent hospital data from 2016 and 2017.
Two House committees on Monday requested a slew of documents from the pharmaceutical company Biogen as part of an investigation into the controversial approval of its Alzheimer's treatment.
House Energy and Commerce Committee Chairman Frank Pallone Jr. (D-N.J.) and House Oversight Committee Chairwoman Carolyn Maloney (D-N.Y.) wrote to Biogen CEO Michel Vounatsos on Monday requesting the documents concerning the Alzheimer's drug, Aduhelm.